Results 10,101-10,120 of 34,618 for speaker:Seán Fleming
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is it a so-called subsidiary?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Dr. Scally is helping in that regard. When will the HSE have the implementation plan?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is it weeks away?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is it only after Dr. Scally has given the plan the okay or made his observations that we will see the implementation plan?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: In other words, Dr. Scally will give it his imprimatur or otherwise.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: These will be issues that he wants added.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Will that be done before Christmas?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: The only observation I will make is that the committee is regularly told recommendations have been made and there is an implementation plan. In the case of other organisations, we have found 12 months later that 70% of the recommendations have been implemented and several have not been implemented. The issue is the follow through. The HSE has accepted the report. This morning, members...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: I put him on notice that in six months or when the time comes he will be before us to explain implementation.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: I apologise for that.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Mr. Breen can do so on the record now.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Before Deputy MacSharry moves on, what information does he want regarding the tests? Will Ms Carr reply now or will she send a written reply?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Is Ms Carr saying that of those whose cases were not accepted by the thalidomide board in Ireland, five went to Sweden and only one was accepted?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Does that answer Deputy MacSharry's questions?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Could Ms Carr also get what is used in Sweden as well?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Ms Carr will send on to the committee the terms of reference and the criteria that were used. Could she have a medical person look at it in order to highlight the differences rather than have us wade through two sets of terms of reference?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Only five of the 63 who did not pass the Irish test went to Sweden.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Will Ms Carr get the information and send it to us?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Does Mr. Breen have a timescale by which the discovery process will be completed to allow him come to a conclusion?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Seán Fleming: Following that, somebody has to assess the discovery and come to a conclusion on how the agency will deal with the case. How long will it take, approximately, before Mr. Breen knows where he will go with the case?